NICM
AXSM icon

Neo Ivy Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Neo Ivy Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-350
Closed -$40.8K – 359
2025
Q1 		$40.8K Buy
+350
New +$39.9K 0.01% 248
2023
Q4 		– Sell
-2,912
Closed -$204K – 296
2023
Q3 		$204K Buy
+2,912
New +$218K 0.09% 226
2022
Q4 		– Sell
-225
Closed -$10K – 336
2022
Q3 		$10K Buy
+225
New +$11.2K 0.03% 320
2020
Q4 		– Sell
-950
Closed -$67K – 417
2020
Q3 		$67K Buy
+950
New +$74K 0.07% 334

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return